Cargando…

Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine

In order to control the H9N2 subtype low pathogenic avian influenza (LPAI), an inactivated vaccine has been used in Korea since 2007. The Korean veterinary authority permitted the use of a single H9N2 LPAI vaccine strain to simplify the evolution of the circulating virus due to the immune pressure c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jun-Gu, Lee, Youn-Jeong, Kim, Ji-Yeon, Kim, Yeon-Hee, Paek, Mi-Ra, Yang, Dong-Kun, Son, Seong-Wan, Kim, Jae-Hong
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Veterinary Science 2010
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873817/ https://www.ncbi.nlm.nih.gov/pubmed/20458158 http://dx.doi.org/10.4142/jvs.2010.11.2.161

Ejemplares similares

Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens
por: Shin, Jeong-Hwa, et al.
Publicado: (2016)

An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea
por: Choi, Jun Gu, et al.
Publicado: (2008)

Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese
por: Lu, Jihu, et al.
Publicado: (2016)

Comparative Evaluation of Immune Responses and Protection of Chitosan Nanoparticles and Oil-Emulsion Adjuvants in Avian Coronavirus Inactivated Vaccines in Chickens
por: Lopes, Priscila Diniz, et al.
Publicado: (2021)

Single PA mutation as a high yield determinant of avian influenza vaccines
por: Lee, Ilseob, et al.
Publicado: (2017)

Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks
por: Teng, Qiaoyang, et al.
Publicado: (2015)

Assessing the efficacy of a recombinant H9N2 avian influenza virus–inactivated vaccine
por: Song, Cai Liang, et al.
Publicado: (2020)

Vaccination with inactivated virus against low pathogenic avian influenza subtype H9N2 does not prevent virus transmission in chickens
por: Cui, Hongrui, et al.
Publicado: (2021)

Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
por: Liu, Yuzhuo, et al.
Publicado: (2023)

Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
por: Zhou, Xiangmei, et al.
Publicado: (2022)

Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles
por: Khalili, Iraj, et al.
Publicado: (2015)

Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine
por: Astill, Jake, et al.
Publicado: (2018)

Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza
por: Zhao, Jing, et al.
Publicado: (2017)

Enhanced pathogenicity of low-pathogenic H9N2 avian influenza virus after vaccination with infectious bronchitis live attenuated vaccine
por: Ismail, Zainab Mohamed, et al.
Publicado: (2018)

Does vaccination with the live mycoplasma vaccine MSH increase the pathogenicity of Avian influenza infections?
por: Morrow, Chris J.
Publicado: (2019)

Inactivation of avian influenza viruses by hydrostatic pressure as a potential vaccine development approach
por: Barroso, Shana Priscila Coutinho, et al.
Publicado: (2021)

Vaccination of poultry against highly pathogenic avian influenza – part 1. Available vaccines and vaccination strategies
por: Nielsen, Søren Saxmose, et al.
Publicado: (2023)

Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus
por: Chua, Tze-Hoong, et al.
Publicado: (2010)

Experimental infection of chickens, ducks and quails with the highly pathogenic H5N1 avian influenza virus
por: Jeong, Ok-Mi, et al.
Publicado: (2009)

Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza
por: Jang, Jin-Wook, et al.
Publicado: (2017)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Pathogenic assessment of avian influenza viruses in migratory birds
por: Kim, Eun-Ha, et al.
Publicado: (2021)

Selection of an Optimal Recombinant Egyptian H9N2 Avian Influenza Vaccine Strain for Poultry with High Antigenicity and Safety
por: An, Se-Hee, et al.
Publicado: (2022)

Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis
por: Lin, Yu-Ju, et al.
Publicado: (2020)

Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
por: Sun, Zhihao, et al.
Publicado: (2021)

Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes
por: Bortolami, Alessio, et al.
Publicado: (2022)

Differential Diagnosis for Highly Pathogenic Avian Influenza Virus Using Nanoparticles Expressing Chemiluminescence
por: Kim, Jihee, et al.
Publicado: (2021)

Effect of Co-infection of Low Pathogenic Avian Influenza H9N2 Virus and Avian Pathogenic E. coli on H9N2-Vaccinated Commercial Broiler Chickens
por: Mahmoud, Sherif I. A., et al.
Publicado: (2022)

Conventional inactivated bivalent H5/H7 vaccine prevents viral localization in muscles of turkeys infected experimentally with low pathogenic avian influenza and highly pathogenic avian influenza H7N1 isolates
por: Toffan, Anna, et al.
Publicado: (2008)

A Population-Based, Nationwide Cross-Sectional Study on Influenza Vaccination Status among Cancer Survivors in Korea
por: Oh, Myeung Guen, et al.
Publicado: (2015)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

H9N2 avian influenza virus in Korea: evolution and vaccination
por: Lee, Dong-Hun, et al.
Publicado: (2013)

A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
por: Couch, Robert B., et al.
Publicado: (2012)

Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins
por: Sun, Hongxiang, et al.
Publicado: (2020)

Perceptions Related to Bird-to-Human Avian Influenza, Influenza Vaccination, and Use of Face Mask
por: Lau, J. T. F., et al.
Publicado: (2008)

Comparative Pathogenicity and Transmissibility of the H7N9 Highly Pathogenic Avian Influenza Virus and the H7N9 Low Pathogenic Avian Influenza Virus in Chickens
por: Yu, Hao, et al.
Publicado: (2019)

Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus (H5N1)
por: Rice, Eugene W., et al.
Publicado: (2007)

The response of mute swans (Cygnus olor, Gm. 1789) to vaccination against avian influenza with an inactivated H5N2 vaccine
por: Dolka, Beata, et al.
Publicado: (2016)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Protective effect of an inactivated avian coronavirus vaccine administered by aerosol
por: Coria, M. F.
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_a6ksokevfros6sk6idtfimcrc4